Breast Adenocarcinoma

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2023-12-18
Clinical Trial Update: TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery [Phase 2]
Phase 2 clinical trial investigating TPIV100 in combination with sargramostim for HER2-positive breast cancer with residual disease after ch…